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Abstract
Background The Short Musculoskeletal Function Assess-
ment (SMFA) is widely used in both research and clinical
practice. Despite its frequent use, normative data of the
SMFA have remained limited. Aim of this study was to
gather normative data for the Dutch SMFA (SMFA-NL).
Methods The SMFA-NL consists of two indices (function
index and bother index) and four subscales (upper ex-
tremity dysfunction, lower extremity dysfunction, mental
and emotional problems, and problems with daily ac-
tivities). A total of 900 patients were invited to fill in the
SMFA-NL. Six age groups (18–24, 25–34, 35–44, 45–54,
55–64, and 65–75 years) were constructed. Analysis of
variance, t tests, and regression analyses were used to
assess age and gender effects.
Results The response rate was 97 %. There was a sig-
nificant difference between men and women in scores on
all indices and subscales (range p\ 0.001 to p = 0.002),
except for the upper extremity dysfunction subscale
(p = 0.06). A significant interaction effect was found be-
tween gender and age for the upper extremity dysfunction
subscale; a larger decrease in score with increasing age was
observed for women, compared with men. Significant
differences were found between age groups for the bother
index (p\ 0.001), lower extremity dysfunction subscale
(p = 0.001), and the problems with daily activities sub-
scale (p = 0.002).
Conclusion Significant differences in SMFA-NL scores
were found between men and women and between differ-
ent age groups. These SMFA-NL normative data provide
an opportunity of benchmarking health status of par-
ticipants with musculoskeletal disorders or injuries against
their age- and gender-matched peers in the Dutch
population.
Keywords Short Musculoskeletal Function Assessment 
Normative data  Dutch  Netherlands  General
population  Patient-reported outcome
Introduction
There has been a marked shift internationally in thinking
about what health is and how it is measured. Traditional
clinical ways of measuring health and the effects of treat-
ment are increasingly accompanied by patient-reported
outcome measures (PROMs) [1]. PROMs can be described
as an outcome reported directly by patients themselves and
not interpreted by an observer. PROMs may include patient
assessments of health status, quality of life, satisfaction
with care or symptoms, or patient-reported adherence to
medication [2]. To date, the use of PROMs is a requirement
for clinical trials, funded by the US Food and Drug Ad-
ministration (FDA) [3]. Since April 2009, the routine col-
lection of PROMs is required by the National Health
Services (NHS) in the UK to measure and improve clinical
quality of specific elective surgical procedures, such as hip
and knee replacement and inguinal hernia repair [4, 5].
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The challenge for clinicians is to interpret the meaning-
fulness of the scores, derived from PROMs. Some additional
information is necessary to place changes in scores, and
scores for different ages and gender, within a clinical context
[6]. Traditionally, comparisons are made between pre- and
post-treatment data to determine whether a treatment is re-
sponsible for change in functioning, relative to a control or
comparison group [7]. However, in studies looking at acute
onset conditions (e.g., injury), participants are often re-
cruited after the health event has taken place. In this case,
participants can be asked to ‘‘recall’’ their pre-onset health
status [8]. Therefore, in studies regarding injured patients,
retrospective measurements of pre-injury health status are
often used for reference values [9–11]. However, these ret-
rospective measurements may be subject to recall bias.
When one is interested in clinical significance, Kendall et al.
raised two basic questions: (a) Is the amount of change that
has occurred, large enough to be considered meaningful and
(b) Are treated individuals distinguishable from ‘‘normal
individuals’’ serving as a reference group [7]? The first
question regards the clinimetric properties of a question-
naire, such as the minimally important change (MIC) and the
smallest detectable change (SDC) [12]. Normative com-
parisons address the second question. Specifically, a nor-
mative comparison addresses the issues of severity.
Normative data can be used to assesswhether patients treated
for specific conditions have returned to or at least have come
closer to their normative ranges of functioning [6, 13]. Fur-
thermore, normative comparison allows the assessment of
the effectiveness of a treatment against a standard indepen-
dent of the patients at issue [7]. Additionally, the absence of
population-based normative values may be a barrier to the
routine use of patient-reported outcome measures (PROMs)
in clinical practice, because of the challenge of interpreting
scores at the individual patient level [14, 15]. In order to
enhance multinational comparisons, PROMs need to be
available in multiple languages, and normative data of these
PROMs for different countries are needed.
The Short Musculoskeletal Function Assessment
(SMFA) is a widely used PROM to assess physical func-
tioning of patients with a variety of musculoskeletal dis-
orders [16]. The SMFA has been cross-culturally adapted
to various languages [17–23]. The SMFA can be used to
assess and compare different types of musculoskeletal in-
juries and disorders. The SMFA is recommended by the
American Academy of Orthopedic Surgeons (AAOS) for
use in clinical practice to assess the effectiveness of
treatment regimens and in musculoskeletal research set-
tings to study the clinical outcomes of treatment [24].
Hence, the SMFA is widely used in clinical research on
musculoskeletal injuries of the upper and lower extremities
[25–27]. The normative values for the SMFA in the general
population of the USA have been published [6, 28].
Recently, the SMFA has been translated and cross-cultur-
ally adapted into Dutch (SMFA-NL) [20]. The SMFA-NL
was found to be a valid and reliable PROM. However,
normative values of the SMFA-NL are not yet established
for the Dutch population. The aim of this study was
therefore to gather normative data of the SMFA-NL in a
general Dutch population sample.
Materials and methods
Questionnaire
The original American SMFA consists of 46 items ordered
as two indices: the function index (34 items) and the bother
index (12 items) [16]. The Dutch version of the SMFA
(SMFA-NL) [20] can be divided, next to the two indices,
into four subscales: the upper extremity dysfunction (6
items), lower extremity dysfunction (12 items), problems
with daily activities (20 items), and mental and emotional
problem (8 item) subscales. All items are scored on a
5-item Likert scale, ranging from 1 (good function/not
bothered) to 5 (poor function/extremely bothered). Total
scores on the subscales are calculated by summing the
responses to the individual items and transforming the
scores so that the range is from 0 to 100, with higher scores
indicating poorer function [16, 20].
Next to basic demographic characteristics, such as age
and gender, information on marital status, educational
level, and current health problems were obtained. Current
health problems (within the previous 6 months) were ob-
tained by means of a questionnaire, comprising 12 chronic
health conditions. This questionnaire is developed by the
Dutch National Institute for Public Health and the Envi-
ronment to assess health conditions of the Dutch popula-
tion [29]. A Web-based questionnaire was developed,
containing the SMFA-NL and questions regarding demo-
graphic characteristics and chronic health conditions.
Sample and data collection
A population-based sample was randomly chosen from the
database of respondents of an independent marketing firm,
which contained postal codes from all provinces of the
Netherlands. Stratified random sampling was used to avoid
bias because of gender and age differences. Furthermore,
the aim was to obtain a fixed precision for each age and
gender group estimate rather than to represent the demo-
graphics of the entire Dutch population. Six age groups
(18–24, 25–34, 35–44, 45–54, 55–64, and 65–75 years)
were constructed. Of these age groups, 50 % of the ap-
proached participants were women. Previous research with
the SMFA-NL has shown a response rate of around 65 %
2016 Qual Life Res (2015) 24:2015–2023
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[6, 20]. Hence, in order to achieve a sample size of 100
participants per age group, a total sample of 900 persons
was recruited. The sample was recruited by e-mail, in
which the purpose of the study was explained, and it
contained a link to the Web site with the electronic ques-
tionnaire. Non-responders were reminded once.
Statistical analysis
Descriptive statistics, including means, standard de-
viations, and 95 % confidence intervals, were calculated to
present the normative data. Data of the subscales were
transposed, so that higher scores indicated better function.
To determine the internal consistency of the American
indices and the four Dutch subscales of the SMFA-NL,
Cronbach’s alpha was calculated. It is widely accepted that
Cronbach’s alpha should be between 0.70 and 0.95 [12].
Differences between men and women were tested with
independent t tests. To assess differences between age
groups, an analysis of variance (ANOVA) with Bonferroni
post hoc analysis was performed. Multiple linear regression
analysis was used to analyze whether there was a sig-
nificant interaction between gender and age groups. Cases
that contained one or more missing items in an index or
subscale of the SMFA-NL were excluded from further
analysis for that certain subscale. Statistical analyses were
performed using IBM SPSS Statistics for Windows, ver-
sion 20.0. Armonk, NY: IBM Corp.
Results
Eight hundred and seventy-five subjects (97 %) responded
to the questionnaire. The demographic characteristics of
the respondents are presented in Table 1. Gender was
equally distributed among the age groups. All of the 875
respondents reported whether they had a chronic health
condition (Table 2). Of the 875 returned questionnaires,
623 (71 %) did not have missing items, 163 (19 %) of the
questionnaires had one missing item, 49 (6 %) had two
missing items, and 40 (5 %) had three or more missing
items. Of the 46 items of the SMFA, item 15 and 22 were
missing in 7.8 and 6.7 % of all, cases respectively
(Table 3). These were items regarding driving a vehicle
and sexual activity. Excellent Cronbach’s alpha values
(C0.87) were obtained for all subscales and indices
(Table 4).
Statistically significant differences in SMFA-NL scores
were found between men and women on all indices and
subscales (ranging from p\ 0.001 to p = 0.002), except
for the upper extremity dysfunction subscale (p = 0.06). A
significant interaction was found between gender and age
groups for the upper extremity dysfunction subscale
(p = 0.03), indicating that the effect of aging on the upper
extremity function is different for men and women. No
interaction effects were found for the other subscales and
indices. These analyses were not adjusted for other de-
mographic characteristics.
Significant differences in scores on the bother index and
two subscales were found between various age groups.
With regard to the bother index, significant differences
were found between age groups 18–24 and 45–54
(p = 0.03), 18–24 and 55–64 (p\ 0.01), and 18–24 and
64–75 (p = 0.03). For the lower extremity dysfunction
subscale, significant differences were seen between age
groups 18–24 and 65–74 (p = 0.03), 25–34 and 55–64
(p = 0.05), and 25–34 and 65–74 (p = 0.01). For the
problems with daily activities subscale, significant differ-
ences were found between age groups 18–24 and 55–64
(p = 0.01), and 25–34 and 55–64 (p = 0.04). No sig-
nificant differences in scores on the function index
(p = 0.22), the upper extremity dysfunction subscale
(p = 0.09), and mental and emotional problems subscale
(p = 0.83) were observed between the age groups.
In Table 5, the normative data of the SMFA-NL are
presented. Mean scores of the function index and bother
index were 88.5 (SD 13.2) and 87.0 (SD 17.5), respec-
tively. Mean scores of the lower extremity dysfunction,
problems with daily activities, and mental and emotional
problems were 89.9 (SD 14.2), 87.8 (SD 17.7), and 78.7
(SD 17.2), respectively. Because of the interaction effect
Table 1 Demographic characteristics of the respondents
Demographics N (%)







Gender (N = 840)
Male 420 (50)
Female 420 (50)
Marital status (N = 811)
Single 220 (27)
With partner 322 (40)
With partner and children 236 (29)
With children 33 (4)
Educational level (N = 864)
Elementary school 22 (3)
High school 307 (35)
College 268 (31)
Bachelor’s degree or higher 267 (31)
Qual Life Res (2015) 24:2015–2023 2017
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Table 2 Reported chronic
health conditions per age group
a Data are presented as N (%)
Age groupsa
18–24 25–34 35–44 45–54 55–64 65–75
Chronic health condition
Migraine 54 (37) 36 (26) 33 (22) 44 (32) 25 (18) 22 (15)
Hypertension 10 (7) 10 (7) 13 (9) 35 (25) 59 (41) 63 (43)
Osteoarthritis 4 (3) 5 (4) 15 (10) 19 (14) 48 (34) 64 (44)
Asthma, chronic bronchitis, lung emphysema 22 (15) 13 (9) 23 (16) 15 (11) 25 (18) 16 (11)
Severe spinal disease, including disc hernia 8 (6) 9 (6) 19 (13) 23 (17) 21 (15) 30 (20)
Inflammatory bowel disease 11 (8) 12 (9) 14 (10) 9 (7) 9 (6) 8 (5)
Rheumatoid arthritis 4 (3) 8 (6) 11 (7) 11 (8) 9 (6) 20 (14)
Diabetes mellitus 2 (1) 3 (2) 3 (2) 8 (6) 15 (12) 33 (23)
Heart failure 2(1) 2 (1) 2 (1) 5 (4) 13 (9) 11 (7)
Myocardial infarction or angina pectoris 2 (1) 1 (1) 1 (1) 1 (1) 7 (5) 14 (10)
Cancer 1 (1) 1 (1) 4 (3) 2 (1) 6 (4) 9 (6)
Stroke 0 (0) 2 (1) 2 (1) 4 (3) 3 (2) 5 (3)
Number of chronic health conditions
None 70 (48) 75 (53) 69 (47) 49 (36) 38 (27) 31 (21)
One 45 (31) 45 (32) 47 (32) 44 (32) 40 (28) 36 (24)
Two 23 (16) 13 (9) 16 (11) 22 (16) 34 (24) 38 (26)
Three or more 8 (5) 8 (6) 16 (11) 23 (17) 31 (22) 43 (29)
Table 3 Number of missing values per item of the SMFA-NL
Number of missing values per item
Item number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Not answered 0 7 3 7 8 4 2 6 8 9 14 13 13 14 68 14
% not answered 0.0 0.8 0.3 0.8 0.9 0.5 0.2 0.7 0.9 1.0 1.6 1.5 1.5 1.6 7.8 1.6
Item number 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32
Not answered 8 6 9 5 6 59 8 4 32 11 22 14 11 11 10 6
% not answered 0.9 0.7 1.0 0.6 0.7 6.7 0.9 0.5 3.7 1.3 2.5 1.6 1.3 1.3 1.1 0.7
Item number 33 34 35 36 37 38 39 40 41 42 43 44 45 46
Not answered 10 7 3 4 3 4 6 7 8 6 9 5 7 5
% not
answered
1.1 0.8 0.3 0.5 0.3 0.5 0.7 0.8 0.9 0.7 1.0 0.6 0.8 0.6
Table 4 Internal consistency of
the SMFA-NL
n No. of items Cronbach’s alpha
Indices
Function Index 643 34 0.96
Bother Index 832 12 0.94
Subscales
Upper extremity dysfunction 842 6 0.91
Lower extremity dysfunction 751 12 0.92
Problems with daily activities 717 20 0.97
Mental and emotional problems 841 8 0.87
2018 Qual Life Res (2015) 24:2015–2023
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between age and gender for the upper extremity dysfunc-
tion subscale, age- and gender-specific normative data are
presented for this subscale. Mean score for the upper ex-
tremity dysfunction subscale was 96.5 (SD 9.3) for men and
93.8 (SD 13.6) and for women.
Age- and gender-specific normative data for all indices
and subscales are presented in ‘‘Appendix.’’
Discussion
The definition of health is changing. WHO defined it in
1948 as ‘‘a state of complete physical, mental and social
well-being and not merely the absence of disease or infir-
mity.’’ Recently, Huber et al. [30] proposed changing the
emphasis toward the ability to adapt and self-manage in the
face of social, physical, and emotional challenges. Patients’
perspective regarding their health status is gaining popu-
larity in clinical research as well as in daily clinical prac-
tice. PROMS are increasingly used to capture these
perspectives.
The SMFA was developed as an instrument to assess
physical functioning of patients with a variety of muscu-
loskeletal disorders [16]. Aim of this study was to gather
normative data of the SMFA-NL of the Dutch population.
Normative data are essential in the process of exploring the
gap between patients with musculoskeletal injuries and the
Table 5 Normative data for the SMFA-NL
N Mean (SD) 95% CI
Indices
Function Index
18–24 121 90.0 (12.2) 87.8–92.2
25–34 112 89.8 (12.7) 87.4–92.2
35–44 113 89.3 (13.3) 86.8–91.8
45–54 98 87.6 (14.1) 84.7–90.4
55–64 106 86.5 (12.7) 84.1–89.0
65–75 83 87.1 (13.5) 84.1–90.0
Males 321 90.2 (11.2) 88.9–91.4
Females 296 86.6 (14.7) 84.9–88.3
Total 643 88.5 (13.2) 87.4–89.5
Bother index
18–24 141 91.3 (14.2) 88.9–93.6
25–34 137 90.6 (14.8) 88.1–93.1
35–44 142 87.0 (19.3) 83.8–90.2
45–54 135 84.6 (18.6) 81.5–87.8
55–64 134 83.1 (17.7) 80.1–86.1
65–75 133 84.7 (18.7) 81.5–87.9
Males 401 88.8 (15.2) 87.3–90.3
Females 398 84.7 (19.5) 82.8–86.7




18–24 47 98.4 (7.6) 96.2–100.0
25–34 53 96.2 (12.2) 92.9–99.6
35–44 57 96.8 (9.2) 94.3–99.2
45–54 76 96.9 (7.2) 95.3–98.6
55–64 86 95.4 (9.2) 93.5–97.5
65–75 83 96.1 (10.1) 93.9–98.3
Total 403 96.5 (9.3) 95.6–97.4
Females
18–24 87 95.8 (10.1) 93.7–98.0
25–34 75 96.6 (10.3) 94.3–99.1
35–44 81 94.1 (15.0) 90.9–97.5
45–54 57 94.2 (13.8) 90.6–97.9
55–64 49 89.2 (13.7) 85.3–93.2
65–75 52 89.5 (17.5) 84.6–94.4
Total 405 93.8 (13.6) 95.4–95.1
Lower extremity dysfunction
18–24 131 92.0 (13.5) 89.6–94.3
25–34 126 92.9 (12.3) 90.7–95.1
35–44 135 90.9 (14.6) 88.4–93.4
45–54 117 89.0 (14.7) 86.3–81.7
55–64 120 87.6 (13.8) 85.1–90.1
65–75 112 86.4 (14.8) 83.6–89.1
Males 369 90.9 (12.8) 90.9–92.2
Females 353 88.8 (15.4) 87.2–90.4
Table 5 continued
N Mean (SD) 95% CI
Total 751 89.9 (14.2) 88.8–90.9
Problems with daily activities
18–24 132 91.4 (14.5) 88.6–93.9
25–34 124 90.5 (15.4) 87.7–93.2
35–44 123 88.7 (16.9) 85.7–91.7
45–54 112 85.2 (19.6) 81.5–88.8
55–64 115 83.9 (17.9) 80.6–87.2
65–75 100 86.0 (17.3) 82.6–89.4
Males 357 89.6 (14.7) 89.6–91.1
Females 329 85.5 (19.3) 83.4–87.6
Total 717 87.8 (17.1) 86.5–89.0
Mental and emotional problems
18–24 141 78.5 (16.0) 75.9–81.2
25–34 138 79.5 (17.2) 76.6–82.4
35–44 144 77.8 (20.1) 74.5–81.1
45–54 133 78.1 (17.6) 75.1–81.2
55–64 138 78.0 (15.3) 75.4–80.6
65–75 137 80.2 (17.1) 77.3–83.1
Males 407 81.9 (15.1) 80.4–83.4
Females 401 75.2 (18.7) 73.3–77.0
Total 841 78.7 (17.2) 77.6–79.9
Qual Life Res (2015) 24:2015–2023 2019
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general population, determining therapeutic effectiveness
or whether a patient has recovered to an acceptable level of
functioning. Yet, it is not clear whether the general
population scores are representative for specific subsets of
the general population, like trauma patients. However, the
general population scores represent an acceptable level of
functioning for those who are recovering from an injury or
disease.
Internal consistency of the two indices and four sub-
scales of the SMFA-NL were high, with Cronbach’s alpha
values exceeding 0.87. These results are in line with pre-
vious studies regarding the clinimetric properties of the
SMFA. Swiontkowski et al. [16] reported high internal
consistency measures (0.95) for both the function index and
bother index of the original SMFA questionnaire. Reininga
et al. [20] reported high Cronbach’s alpha values ([0.85)
for the SMFA-NL. These values were comparable to other
cross-cultural adaptation studies of the SMFA as well [18,
21–23].
Little normative data of the SMFA have been published.
Hunsaker et al. [6] reported normative data for the general
population of the USA. The normative data for the function
index and the bother index found in this study are com-
parable to the normative data found by Hunsaker et al. [6].
However, Hunsaker et al. [6] have not presented normative
data for men and women separately, nor for different age
groups. These have been presented by Barei et al. [28], but
only for the function index.
In this study, significant differences in SMFA-NL scores
between men and women were found for both indices and
all subscales, except for the upper extremity dysfunction
subscale. Barei et al. [28] also reported significant differ-
ences in normative values of the function index between
men and women. The difference in scores of the upper
extremity dysfunction subscale between men and women
was borderline significant (p = 0.06).
The present study showed significant differences be-
tween age groups in scores on the bother index, and the
lower extremity dysfunction and problems with daily ac-
tivities subscales. Further exploration showed that these
results were due to differences between the two youngest
(18–24 and 25–34) and the two eldest (55–64 and 65–75)
age groups. These differences in SMFA-NL scores might
be due to aging.
A significant interaction effect was found in this study
between gender and age for the upper extremity dysfunc-
tion subscale. Scores on the upper extremity dysfunction
subscale showed a larger decrease in score with increasing
age for women, compared to men. Differences in SMFA
scores between age groups or an interaction effect between
gender and age have not been reported in previous studies
on normative values of the SMFA. This same kind of in-
teraction between age and gender has been found in
normative data of the Disabilities of Arm, Shoulder and
Hand (DASH) PROM [31].
Interpretability (e.g., the clinical relevance) of the (dif-
ferences in) scores on the indices and subscales of the
SMFA-NL remains difficult, since a minimal important
change (MIC) score has not yet been established. Hence,
further research into the interpretability of the SMFA, such
as the minimally important change, is needed.
Some strong points and limitations of this study have to
be addressed. First of all, the response rate in this study was
high (97 %), and overall, the number of missing values was
low. Questions regarding driving a vehicle and sexual ac-
tivity had the most missing values (7.8 and 6.7 %, re-
spectively). Both questions were more often left
unanswered by elderly. Additionally, the sample size of the
age- and gender-specific normative data might be seen as a
possible limitation. However, the 95 % confidence inter-
vals of the age- and gender-specific normative data were
narrow. Additionally, because the sampling of this study
was gender- and age group specific, demographic data of
the total study population were slightly different from the
total Dutch population. However, the study sample was
randomly drawn from a large database that contained
postal codes of all Dutch provinces. Overall, the prevalence
of reported chronic diseases and multimorbidity in the
present study were slightly higher compared with other
data reported for the Dutch population [33]. However,
these data for the Dutch population were based on data
provided by Dutch general practitioners. Several studies
have shown that, when using self-reported questionnaires,
the prevalence of chronic diseases is higher compared with
data reported by the general practitioner [34, 35]. However,
per age group, demographic data were considered to be
representative for the Dutch population [32].
In conclusion, this study provides normative data for the
Dutch SMFA (SMFA-NL). The normative values were
comparable to previously published normative data of the
SMFA. Significant differences in SMFA-NL scores were
found between men and women and between different age
groups, which stresses the importance of presenting age-
and gender-specific normative values of the SMFA-NL.
These SMFA-NL normative values provide an opportunity
of benchmarking health status of participants with mus-
culoskeletal disorders or injuries against their age- and
gender-matched peers in the Dutch population. Whether
these values are representative for specific subsamples of
the general population, for example trauma patients, has to
be established.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
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Appendix: Age- and gender-specific normative data
for the SMFA-NL




18–24 38 93.8 (8.2) 91.1–96.5 18–24 78 88.4 (13.0) 84.5–91.3
25–34 46 91.0 (14.2) 86.7–95.2 25–34 62 88.6 (11.9) 85.6–91.6
35–44 50 91.1 (11.6) 87.6–94.4 35–44 61 87.7 (14.6) 83.9–91.4
45–54 63 88.0 (13.6) 84.6–91.5 45–54 33 87.0 (15.6) 81.5–92.5
55–64 66 89.1 (9.7) 86.8–91.5 55–64 36 82.0 (15.4) 76.8–87.2
65–75 57 89.8 (8.1) 87.7–91.9 65–75 22 79.6 (21.2) 70.2–89.0
Total 321 90.2 (11.2) 88.9–91.4 Total 296 86.6 (14.7) 84.9–88.3
Bother Index
Males Females
18–24 46 94.1 (10.1) 91.1–97.1 18–24 91 89.5 (16.0) 86.2–92.8
25–34 54 93.1 (13.8) 89.3–96.9 25–34 75 88.0 (15.7) 84.4–91.6
35–44 62 91.1 (14.2) 87.5–94.7 35–44 78 83.5 (22.2) 78.5–88.5
45–54 74 86.3 (17.2) 82.3–90.3 45–54 57 82.5 (20.5) 77.1–88.0
55–64 84 86.1 (15.3) 82.8–89.4 55–64 46 77.9 (19.9) 72.0–83.8
65–75 80 86.1 (15.8) 82.6–89.7 65–75 48 81.3 (22.9) 74.7–88.0




18–24 47 98.4 (7.6) 96.2–100.0 18–24 87 95.8 (10.1) 93.7–98.0
25–34 53 96.2 (12.2) 92.9–99.6 25–34 75 96.6 (10.3) 94.3–99.1
35–44 57 96.8 (9.2) 94.3–99.2 35–44 81 94.1 (15.0) 90.9–97.5
45–54 76 96.9 (7.2) 95.3–98.6 45–54 57 94.2 (13.8) 90.6–97.9
55–64 86 95.4 (9.2) 93.5–97.5 55–64 49 89.2 (13.7) 85.3–93.2
65–75 83 96.1 (10.1) 93.9–98.3 65–75 52 89.5 (17.5) 84.6–94.4
Total 403 96.5 (9.3) 95.6–97.4 Total 405 93.8 (13.6) 95.4–95.1
Lower extremity dysfunction
Males Females
18–24 40 96.4 (8.1) 93.7–99.0 18–24 86 90.1 (14.5) 87.0–93.2
25–34 50 92.6 (14.3) 88.5–96.6 25–34 70 92.9 (11.1) 90.2–95.5
35–44 59 93.4 (11.6) 90.4–96.4 35–44 74 88.8 (16.6) 84.9–92.6
45–54 68 89.0 (15.8) 85.1–92.8 45–54 47 89.0 (13.5) 85.0–92.9
55–64 77 89.7 (10.8) 87.2–92.1 55–64 39 83.9 (17.4) 78.2–89.5
65–75 74 87.5 (12.3) 84.6–90.4 65–75 33 83.0 (19.5) 76.1–89.9
Total 369 90.9 (12.8) 89.5–92.2 Total 353 88.8 (15.4) 87.2–15.4
Problems with daily activities
Males Females
18–24 44 94.3 (10.4) 91.2–97.5 18–24 84 89.5 (16.4) 86.0–93.1
25–34 50 92.3 (15.8) 87.8–96.8 25–34 67 88.6 (15.7) 84.8–92.4
35–44 57 91.3 (13.2) 87.8–94.4 35–44 64 86.3 (19.6) 81.4–91.2
45–54 68 86.7 (17.6) 82.5–91.0 45–54 40 82.4 (22.9) 75.0–89.7
55–64 72 87.0 (14.9) 83.5–90.5 55–64 39 78.5 (20.6) 71.8–85.2
65–75 65 88.4 (13.4) 85.1–91.8 65–75 31 79.4 (23.0) 71.0–87.9
Total 357 89.6 (14.7) 88.0–91.1 Total 329 85.5 (19.3) 19.3–87.6
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